BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31625596)

  • 1. Power calculation for cross-sectional stepped wedge cluster randomized trials with variable cluster sizes.
    Harrison LJ; Chen T; Wang R
    Biometrics; 2020 Sep; 76(3):951-962. PubMed ID: 31625596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unequal cluster sizes in stepped-wedge cluster randomised trials: a systematic review.
    Kristunas C; Morris T; Gray L
    BMJ Open; 2017 Nov; 7(11):e017151. PubMed ID: 29146637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes.
    Tian Z; Preisser JS; Esserman D; Turner EL; Rathouz PJ; Li F
    Biom J; 2022 Mar; 64(3):419-439. PubMed ID: 34596912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power calculation for analyses of cross-sectional stepped-wedge cluster randomized trials with binary outcomes via generalized estimating equations.
    Harrison LJ; Wang R
    Stat Med; 2021 Dec; 40(29):6674-6688. PubMed ID: 34558112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model.
    Blaha O; Esserman D; Li F
    Stat Med; 2022 Oct; 41(24):4860-4885. PubMed ID: 35908796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculations for stepped wedge and cluster randomised trials: a unified approach.
    Hemming K; Taljaard M
    J Clin Epidemiol; 2016 Jan; 69():137-46. PubMed ID: 26344808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiency of unequal cluster sizes in stepped wedge and other trial designs under longitudinal or cross-sectional sampling.
    Girling AJ
    Stat Med; 2018 Dec; 37(30):4652-4664. PubMed ID: 30209812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size calculation for stepped-wedge cluster-randomized trials with more than two levels of clustering.
    Teerenstra S; Taljaard M; Haenen A; Huis A; Atsma F; Rodwell L; Hulscher M
    Clin Trials; 2019 Jun; 16(3):225-236. PubMed ID: 31018678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.
    Chen J; Zhou X; Li F; Spiegelman D
    Comput Methods Programs Biomed; 2022 Jan; 213():106522. PubMed ID: 34818620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped-wedge cluster randomized trials.
    Lee KM; Ma X; Yang GM; Cheung YB
    Stat Med; 2022 Jul; 41(15):2923-2938. PubMed ID: 35352382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid approach to comparing parallel-group and stepped-wedge cluster-randomized trials with a continuous primary outcome when there is uncertainty in the intra-cluster correlation.
    Sarkodie SK; Wason JM; Grayling MJ
    Clin Trials; 2023 Feb; 20(1):59-70. PubMed ID: 36086822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stepped-wedge cluster randomised controlled trials: a generic framework including parallel and multiple-level designs.
    Hemming K; Lilford R; Girling AJ
    Stat Med; 2015 Jan; 34(2):181-96. PubMed ID: 25346484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical issues in the design and conduct of stepped-wedge cluster randomized trials in low-resource settings.
    Joag K; Ambrosio G; Kestler E; Weijer C; Hemming K; Van der Graaf R
    Trials; 2019 Dec; 20(Suppl 2):703. PubMed ID: 31852547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflection on modern methods: when is a stepped-wedge cluster randomized trial a good study design choice?
    Hemming K; Taljaard M
    Int J Epidemiol; 2020 Jun; 49(3):1043-1052. PubMed ID: 32386407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes.
    Ouyang Y; Karim ME; Gustafson P; Field TS; Wong H
    BMC Med Res Methodol; 2020 Jun; 20(1):166. PubMed ID: 32580698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
    Zhan D; Ouyang Y; Xu L; Wong H
    Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.